Skip to main content
. 2021 Feb 19;10(2):444. doi: 10.3390/cells10020444

Table 1.

Clinical–pathological features of patients (n = 45).

Subgroup No. of Patients
Age
< 65 30 (67%)
> 65 15 (33%)
Gender:
Female 23 (51%)
Male 22 (49%)
Tumour site:
Head 19 (42%)
Body-Tail 26 (58%)
TNM by AJCC Stage
T2N0–1M0 20 (44%)
T3N0–1M0 25 (56%)
Histologic type
Ductal adenocarcinomas 45 (100%)
Histologic grade
G1–G2 34 (77%)
G3 11 (23%)